The Diagnostic Impact of Color Vision - Top-Institutions - MDSpire

The Diagnostic Impact of Color Vision

Study suggests reduced survival in bladder cancer patients with color vision deficiency

  • March 30, 2026

  • 2 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Cancer Epidemiology
    • Urology

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Oncology
    • Ophthalmology
    • Epidemiology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Oncology
    • Ophthalmology
    • Clinical Research

  • #4

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Oncology
    • Ophthalmology
    • Health Informatics

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Oncology
    • Ophthalmology
    • Public Health

Original Source(s)

The Diagnostic Impact of Color Vision

  • March 30, 2026

Related Content

The Next Wave of Immune Cell Therapy

From CAR T to eTCR: New immune cell therapies push beyond blood cancers

  • April 1, 2026

  • 18 min
This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

  • May 12, 2026

  • 7 min
Proton Therapy in Early-Onset Locally Advanced Rectal Cancer: The Importance of Fertility-Preserving Multimodality Care

The rising incidence and mortality of early-onset colorectal cancer (EOCRC), defined as disease occurring in patients younger than 50, has emerged as a clinically significant trend with implications for screening, diagnosis, and survivorship.

  • April 28, 2026

  • 5 min